HomeTLX • NASDAQ
Telix Pharmaceuticals American Depositary Shares
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 195.18M | 58.88% |
Operating expense | 95.47M | 43.78% |
Net income | -1.15M | -115.08% |
Net profit margin | -0.59 | -109.53% |
Earnings per share | — | — |
EBITDA | 2.93M | -58.16% |
Effective tax rate | 52.61% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 207.16M | 161.27% |
Total assets | 1.19B | 139.09% |
Total liabilities | 768.01M | 236.59% |
Total equity | 421.94M | — |
Shares outstanding | 338.40M | — |
Price to book | 8.04 | — |
Return on assets | -0.12% | — |
Return on capital | -0.17% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.15M | -115.08% |
Cash from operations | 8.87M | -54.91% |
Cash from investing | -129.43M | -428.60% |
Cash from financing | -1.46M | -160.91% |
Net change in cash | -116.42M | -2,260.99% |
Free cash flow | -3.60M | -105.50% |
Previous close
$10.05
Day range
$10.57 - $11.08
Year range
$8.93 - $30.36
Market cap
5.54B AUD
Avg Volume
231.80K
P/E ratio
-
Dividend yield
-
About
Founded
2015
Website
Employees
423
